Aggregatibacter actinomycetemcomitans: Virulence of its leukotoxin and association with aggressive periodontitis

Virulence

Volumn 6, Issue 3, 2015, Pages 188-195

  Åberg, Carola Höglund ^a   Kelk, Peyman ^a   Johansson, Anders ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Aggregatibacter actinomycetemcomitans; Aggressive periodontitis; Bone resorption; IL 1 ; Infection; Inflammation; Leukotoxin

Indexed keywords

INFLAMMASOME; LEUKOTOXIN; OSTEOCLAST DIFFERENTIATION FACTOR; VIRULENCE FACTOR; EXOTOXIN; INTERLEUKIN 1BETA;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; AGGRESSIVE PERIODONTITIS; APOPTOSIS; BACTERIAL COLONIZATION; BIOFILM; GENE EXPRESSION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; REVIEW; ADOLESCENT; BIOSYNTHESIS; CASE REPORT; ETIOLOGY; FEMALE; GENETIC VARIATION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; OSTEOLYSIS; PATHOGENICITY;

NEGIBACTERIA;

ADOLESCENT; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; AGGRESSIVE PERIODONTITIS; BONE RESORPTION; EXOTOXINS; FEMALE; GENETIC VARIATION; HUMANS; INTERLEUKIN-1BETA; VIRULENCE FACTORS;

EID: 84927767211     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/21505594.2014.982428     Document Type: Review

References (82)

1. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell 2010; 140:771-6; PMID:20303867; http://dx.doi.org/10.1016/j.cell.2010.03.006
2. Hajishengallis G. Immunomicrobial pathogenesis of periodontitis: keystones, pathobionts, and host response. Trends immunol 2014; 35:3-11; PMID:24269668; http://dx.doi.org/10.1016/j.it.2013. 09.001
3. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005; 366:1809-20; PMID:16298220; http://dx.doi.org/10.1016/S0140- 6736(05)67728-8
4. Nibali L, Donos N, Henderson B. Periodontal infectogenomics. J Med Microbiol 2009; 58:1269-74; PMID:19528161; http://dx.doi.org/10.1099/jmm.0. 012021-0
5. Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, Taubert KA, Newburger JW, Gornik HL, Gewitz MH, et al. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation 2012; 125:2520-44; PMID:22514251; http://dx. doi.org/10.1161/CIR.0b013e31825719f3
6. D’Aiuto F, Parkar M, Nibali L, Suvan J, Lessem J, Tonetti MS. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am Heart J 2006; 151:977-84; PMID:16644317; http://dx.doi. org/10.1016/j.ahj.2005.06.018
7. Teles R, Teles F, Frias-Lopez J, Paster B, Haffajee A. Lessons learned and unlearned in periodontal microbiology. Periodontology 2000 2013; 62:95-162; PMID:23574465; http://dx.doi.org/10.1111/prd.12010
8. Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontology 2000 2005; 38:135-87; PMID:15853940; http://dx.doi.org/10.1111/j.1600- 0757.2005.00107.x
9. Hanage WP. Microbiology: Microbiome science needs a healthy dose of scepticism. Nature 2014; 512:247-8; PMID:25143098; http://dx.doi.org/10.1038/512247a
10. Marsh PD. Are dental diseases examples of ecological catastrophes? Microbiol 2003; 149:279-94; PMID:12624191; http://dx.doi.org/10.1099/mic.0. 26082-0
11. Kononen E, Muller HP. Microbiology of aggressive periodontitis. Periodontol 2000 2014; 65:46-78; PMID:24738586; http://dx.doi.org/10.1111/prd.12016
12. Albandar JM. Aggressive and acute periodontal diseases. Periodontol 2000 2014; 65:7-12; PMID:24738583; http://dx.doi.org/10.1111/prd.12013
13. Nibali L, Farias BC, Vajgel A, Tu YK, Donos N. Tooth loss in aggressive periodontitis: a systematic review. J Dent Res 2013; 92:868-75; PMID:23955159; http:// dx.doi.org/10.1177/0022034513501878
14. Westergaard J, Frandsen A, Slots J. Ultrastructure of the subgingival microflora in juvenile periodontitis. Scand J Dent Res 1978; 86:421-9; PMID:284566
15. Listgarten MA. Structure of the microbial flora associated with periodontal health and disease in man. A light and electron microscopic study. J Periodontol 1976; 47:1-18; PMID:1063849; http://dx.doi.org/10.1902/ jop.1976.47.1.1
16. Chung HJ, Chung CP, Son SH, Nisengard RJ. Actinobacillus actinomycetemcomitans serotypes and leukotoxicity in Korean localized juvenile periodontitis. J Periodontol 1989; 60:506-11; PMID:2677302; http:// dx.doi.org/10.1902/jop.1989.60.9.506
17. Haubek D, Ennibi OK, Poulsen K, Vaeth M, Poulsen S, Kilian M. Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: a prospective longitudinal cohort study. Lancet 2008; 371:237-42; PMID:18207019; http://dx.doi.org/ 10.1016/S0140-6736(08)60135-X
18. Henderson B, Ward JM, Ready D. Aggregatibacter (Actinobacillus) actinomycetemcomitans: a triple A* periodontopathogen? Periodontol 2000 2010; 54:78- 105; PMID:20712635; http://dx.doi.org/10.1111/ j.1600-0757.2009.00331.x
19. Takada K, Saito M, Tsuzukibashi O, Kawashima Y, Ishida S, Hirasawa M. Characterization of a new serotype g isolate of Aggregatibacter actinomycetemcomitans. Mol Oral Microbiol 2010; 25:200-6; PMID:20536747; http://dx.doi.org/10.1111/j.2041- 1014.2010.00572.x
20. Kittichotirat W, Bumgarner RE, Asikainen S, Chen C. Identification of the pangenome and its components in 14 distinct Aggregatibacter actinomycetemcomitans strains by comparative genomic analysis. PloS one 2011; 6:e22420; PMID:21811606; http://dx.doi.org/ 10.1371/journal.pone.0022420
21. Fine DH, Markowitz K, Furgang D, Fairlie K, Ferrandiz J, Nasri C, McKiernan M, Gunsolley J. Aggregatibacter actinomycetemcomitans and its relationship to initiation of localized aggressive periodontitis: longitudinal cohort study of initially healthy adolescents. J Clin Microbiol 2007; 45:3859-69; PMID:17942658; http://dx.doi.org/10.1128/JCM.00653-07
22. Fine DH, Markowitz K, Furgang D, Velliyagounder K. Aggregatibacter actinomycetemcomitans as an early colonizer of oral tissues: epithelium as a reservoir? J Clin Microbiol 2010; 48:4464-73; PMID:20881174; http://dx.doi.org/10.1128/JCM.00964-10
23. Hoglund Aberg C, Kwamin F, Claesson R, Dahlen G, Johansson A, Haubek D. Progression of attachment loss is strongly associated with presence of the JP2 genotype of Aggregatibacter actinomycetemcomitans: a prospective cohort study of a young adolescent population. J Clin Periodontol 2014; 41:232-41; PMID:24304011; http://dx.doi.org/10.1111/jcpe.12209
24. Brogan JM, Lally ET, Poulsen K, Kilian M, Demuth DR. Regulation of Actinobacillus actinomycetemcomitans leukotoxin expression: analysis of the promoter regions of leukotoxic and minimally leukotoxic strains. Infect Immun 1994; 62:501-8; PMID:8300209
25. Johansson A. Aggregatibacter actinomycetemcomitans leukotoxin: a powerful tool with capacity to cause imbalance in the host inflammatory response. Toxins 2011; 3:242-59; PMID:22069708; http://dx.doi.org/ 10.3390/toxins3030242
26. Hoglund Aberg C, Haubek D, Kwamin F, Johansson A, Claesson R. Leukotoxic Activity of Aggregatibacter actinomycetemcomitans and Periodontal Attachment Loss. PloS one 2014; 9:e104095; PMID:25093857; http://dx.doi.org/10.1371/journal.pone.0104095
27. Shilo S, Kassis I, Hakim F, Shachor-Meyouhas Y. Aggregatibacter actinomycemcomitans Pneumonia in Children: Two Case Reports and a Review of the Literature. Pediatr Infect Dis J 2014; PMID:25068288
28. Das M, Badley AD, Cockerill FR, Steckelberg JM,Wilson WR. Infective endocarditis caused by HACEK microorganisms. Annu Rev Med 1997; 48:25-33; PMID:9046942; http://dx.doi.org/10.1146/annurev. med.48.1.25
29. Norskov-Lauritsen N. Classification, identification, and clinical significance of haemophilus and aggregatibacter species with host specificity for humans. Clin Microbiol Rev 2014; 27:214-40; PMID:24696434; http://dx.doi. org/10.1128/CMR.00103-13
30. Linhartova I, Bumba L, Masin J, Basler M, Osicka R, Kamanova J, Prochazkova K, Adkins I, Hejnova-Holubova J, Sadilkova L, et al. RTX proteins: a highly diverse family secreted by a common mechanism. FEMS Microbiol Rev 2010; 34:1076-112; PMID:20528947
31. Belibasakis GN. Cellular and molecular responses of periodontal connective tissue cells to Actinobacillus actinomycetemcomitans cytolethal distending toxin. Odontological Dissertation, Faculty of Medicine: Umeå University, 2004:49
32. Belibasakis GN, Johansson A, Wang Y, Chen C, Kalfas S, Lerner UH. The cytolethal distending toxin induces receptor activator of NF-kappaB ligand expression in human gingival fibroblasts and periodontal ligament cells. Infect Immun 2005; 73:342-51; PMID:15618171; http://dx.doi.org/10.1128/ IAI.73.1.342-351.2005
33. Hoglund Aberg C, Antonoglou G, Haubek D, Kwamin F, Claesson R, Johansson A. Cytolethal distending toxin in isolates of Aggregatibacter actinomycetemcomitans from Ghanaian adolescents and association with serotype and disease progression. PloS one 2013; 8: e65781; PMID:23922633; http://dx.doi.org/10.1371/ journal.pone.0065781
34. Lally ET, Hill RB, Kieba IR, Korostoff J. The interaction between RTX toxins and target cells. Trends Microbiol 1999; 7:356-61; PMID:10470043; http:// dx.doi.org/10.1016/S0966-842X(99)01530-9
35. Kelk P, Johansson A, Claesson R, Hanstrom L, Kalfas S. Caspase 1 involvement in human monocyte lysis induced by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun 2003; 71:4448-55; PMID:12874324; http://dx.doi.org/10.1128/IAI.71. 8.4448-4455.2003
36. Claesson R, Johansson A, Belibasakis G, Hanstrom L, Kalfas S. Release and activation of matrix metalloproteinase 8 from human neutrophils triggered by the leukotoxin of Actinobacillus actinomycetemcomitans. J Periodontal Res 2002; 37:353-9; PMID:12366858; http://dx.doi.org/10.1034/j.1600-0765.2002.00365.x
37. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87:2095-147; PMID:8630372
38. Delima AJ, Van Dyke TE. Origin and function of the cellular components in gingival crevice fluid. Periodontol 2000 2003; 31:55-76; PMID:12656996; http://dx. doi.org/10.1034/j.1600-0757.2003.03105.x
39. Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol 2008; 79:1585-91; PMID:18673014; http://dx.doi.org/10.1902/jop.2008. 080183
40. Lerner UH. Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. J Dent Res 2006; 85:596-607; PMID:16798858; http://dx.doi.org/10.1177/15440 5910608500704
41. Jules J, Zhang P, Ashley JW, Wei S, Shi Z, Liu J, Michalek SM, Feng X. Molecular basis of requirement of receptor activator of nuclear factor kappaB signaling for interleukin 1-mediated osteoclastogenesis. J Biol Chem 2012; 287:15728-38; PMID:22416138; http:// dx.doi.org/10.1074/jbc.M111.296228
42. Kelk P, Claesson R, Hanstrom L, Lerner UH, Kalfas S, Johansson A. Abundant secretion of bioactive interleukin- 1beta by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun 2005; 73:453-8; PMID:15618184; http://dx. doi.org/10.1128/IAI.73.1.453-458.2005
43. Kelk P, Claesson R, Chen C, Sjostedt A, Johansson A. IL-1beta secretion induced by Aggregatibacter (Actinobacillus) actinomycetemcomitans is mainly caused by the leukotoxin. Int J Med Microbiol : IJMM 2008; 298:529-41; PMID:17888725; http://dx.doi.org/ 10.1016/j.ijmm.2007.06.005
44. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-b. Mol Cell 2002; 10:417-26; PMID:12191486; http://dx.doi.org/ 10.1016/S1097-2765(02)00599-3
45. McIntire CR, Yeretssian G, Saleh M. Inflammasomes in infection and inflammation. Apoptosis 2009; PMID:19156527
46. Yu HB, Finlay BB. The caspase-1 inflammasome: a pilot of innate immune responses. Cell Host Microbe 2008; 4:198-208; PMID:18779046; http://dx.doi.org/ 10.1016/j.chom.2008.08.007
47. Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 2009; 7:99-109; PMID:19148178; http://dx.doi.org/ 10.1038/nrmicro2070
48. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009; 16:3-11; PMID:18846107; http://dx.doi.org/ 10.1038/cdd.2008.150
49. Dinarello CA. Interleukin-1 b, interleukin-18, and the interleukin-1 b converting enzyme. Ann N Y Acad Sci 1998; 856:1-11; PMID:9917859; http://dx.doi.org/ 10.1111/j.1749-6632.1998.tb08307.x
50. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23:479-90; PMID:16286016; http://dx.doi.org/ 10.1016/j.immuni.2005.09.015
51. Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infection and immunity 2005; 73:1907-16; PMID:15784530; http://dx.doi.org/ 10.1128/IAI.73.4.1907-1916.2005
52. Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, Idzko M, Panther E, Di Virgilio F. The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 2006; 176:3877-83; PMID:16547218; http://dx.doi.org/10.4049/jimmunol.176.7.3877
53. Dinarello CA. Interleukin-1beta. Crit Care Med 2005; 33:S460-2; PMID:16340421; http://dx.doi.org/ 10.1097/01.CCM.0000185500.11080.91
54. Kelk P, Abd H, Claesson R, Sandstrom G, Sjostedt A, Johansson A. Cellular and molecular response of human macrophages exposed to Aggregatibacter actinomycetemcomitans leukotoxin. Cell death & disease 2011; 2:e126; PMID:21390060; http://dx.doi.org/ 10.1038/cddis.2011.6
55. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8:958-69; PMID:19029990; http://dx.doi.org/ 10.1038/nri2448
56. Belibasakis GN, Johansson A. Aggregatibacter actinomycetemcomitans targets NLRP3 and NLRP6 inflammasome expression in human mononuclear leukocytes. Cytokine 2012; 59:124-30; PMID:22503597; http:// dx.doi.org/10.1016/j.cyto.2012.03.016
57. Mariathasan S, Weiss DS, Newton K, McBride J, O’Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006; 440:228-32; PMID:16407890; http://dx.doi. org/10.1038/nature04515
58. Mariathasan S, Weiss DS, Dixit VM, Monack DM. Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J Exp Med 2005; 202:1043-9; PMID:16230474; http://dx.doi.org/ 10.1084/jem.20050977
59. Boch JA, Wara-aswapati N, Auron PE. Interleukin 1 signal transduction-current concepts and relevance to periodontitis. J Dent Res 2001; 80:400-7; PMID:11332522; http://dx.doi.org/10.1177/002203 45010800020101
60. Gravallese EM, Goldring SR. Cellular mechanisms and the role of cytokines in bone erosions in rheumatoid arthritis. Arthritis Rheum 2000; 43:2143-51; PMID:11037873; http://dx.doi.org/10.1002/1529- 0131(200010)43:10<2143::AID-ANR1>3.0.CO;2-S
61. Holmlund A, Hanstrom L, Lerner UH. Bone resorbing activity and cytokine levels in gingival crevicular fluid before and after treatment of periodontal disease. J Clin Periodontol 2004; 31:475-82; PMID:15142219; http://dx.doi.org/10.1111/j.1600-051X.2004.00504.x
62. Kornman KS, di Giovine FS. Genetic variations in cytokine expression: a risk factor for severity of adult periodontitis. Ann Periodontol 1998; 3:327-38; PMID:9722717; http://dx.doi.org/10.1902/annals. 1998.3.1.327
63. Timmerman MF, Van der Weijden GA, Abbas F, Arief EM, Armand S, Winkel EG, Van Winkelhoff AJ, Van der Velden U. Untreated periodontal disease in Indonesian adolescents. Longitudinal clinical data and prospective clinical and microbiological risk assessment. J Clin Periodontol 2000; 27:932-42; PMID:11140561; http://dx.doi.org/10.1034/j.1600-051x.2000.02701 2932.x
64. Van der Velden U, Abbas F, Armand S, Loos BG, Timmerman MF, Van der Weijden GA, Van Winkelhoff AJ, Winkel EG. Java project on periodontal diseases. The natural development of periodontitis: risk factors, risk predictors and risk determinants. J Clin Periodontol 2006; 33:540-8; PMID:16899096; http://dx.doi. org/10.1111/j.1600-051X.2006.00953.x
65. Silveira VR, Nogueira MV, Nogueira NA, Lima V, Furlaneto FA, Rego RO. Leukotoxicity of Aggregatibacter actinomycetemcomitans in generalized aggressive periodontitis in Brazilians and their family members. J Appl Oral Sci 2013; 21:430-6; PMID:24212989; http://dx.doi.org/10.1002/app.38187
66. Haubek D. The highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans: evolutionary aspects, epidemiology and etiological role in aggressive periodontitis. APMIS Suppl 2010:1-53; PMID:21214629; http://dx.doi.org/10.1111/j.1600- 0463.2010.02665.x
67. Haubek D, Johansson A. Pathogenicity of the highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans and its geographic dissemination and role in aggressive periodontitis. J Oral Microbiol 2014; 6; PMID:25206940; http://dx.doi.org/10.3402/jom.v6.23980
68. Haraszthy VI, Hariharan G, Tinoco EM, Cortelli JR, Lally ET, Davis E, Zambon JJ. Evidence for the role of highly leukotoxic Actinobacillus actinomycetemcomitans in the pathogenesis of localized juvenile and other forms of early-onset periodontitis. J Periodontol 2000; 71:912-22; PMID:10914794; http://dx.doi.org/ 10.1902/jop.2000.71.6.912
69. Elamin A, Albandar JM, Poulsen K, Ali RW, Bakken V. Prevalence of Aggregatibacter actinomycetemcomitans in Sudanese patients with aggressive periodontitis: a case-control study. J Periodontal Res 2011; 46:285- 91; PMID:21332472; http://dx.doi.org/10.1111/ j.1600-0765.2010.01337.x
70. Zambon JJ. Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol 1985; 12:1-20; PMID:3882766; http://dx.doi.org/10.1111/ j.1600-051X.1985.tb01348.x
71. Dahlen G, Claesson R, Aberg CH, Haubek D, Johansson A, Kwamin F. Subgingival bacteria in Ghanaian adolescents with or without progression of attachment loss. J Oral Microbiol 2014; 6; PMID:24834145; http://dx.doi.org/10.3402/jom.v6.23977
72. Johansson A, Hanstrom L, Kalfas S. Inhibition of Actinobacillus actinomycetemcomitans leukotoxicity by bacteria from the subgingival flora. Oral Microbiol Immunol 2000; 15:218-25; PMID:11154406; http:// dx.doi.org/10.1034/j.1399-302x.2000.150402.x
73. Haraguchi A, Miura M, Fujise O, Hamachi T, Nishimura F. Porphyromonas gingivalis gingipain is involved in the detachment and aggregation of Aggregatibacter actinomycetemcomitans biofilm. Mol Oral Microbiol 2014; 29:131-43; PMID:24661327; http:// dx.doi.org/10.1111/omi.12051
74. Takasaki K, Fujise O, Miura M, Hamachi T, Maeda K. Porphyromonas gingivalis displays a competitive advantage over Aggregatibacter actinomycetemcomitans in co-cultured biofilm. J Periodontal Res 2013; 48:286-92; PMID:23033940; http://dx.doi.org/ 10.1111/jre.12006
75. Chen C, Wang T, Chen W. Occurrence of Aggregatibacter actinomycetemcomitans serotypes in subgingival plaque from United States subjects. Molecular oral microbiology 2010; 25:207-14; PMID:20536748; http://dx.doi.org/10.1111/j.2041-1014.2010.00567.x
76. Nibali L, D’Aiuto F, Ready D, Parkar M, Yahaya R, Donos N. No association between A actinomycetemcomitans or P gingivalis and chronic or aggressive periodontitis diagnosis. Quintessence Int 2012; 43:247-54; PMID:22299125
77. McArthur WP, Tsai CC, Baehni PC, Genco RJ, Taichman NS. Leukotoxic effects of Actinobacillus actinomycetemcomitans. Modulation by serum components. J Periodontal Res 1981; 16:159-70; PMID:6453979; http://dx.doi.org/ 10.1111/j.1600-0765.1981.tb00962.x
78. Johansson A, Claesson R, Belibasakis G, Makoveichuk E, Hanstrom L, Olivecrona G, Kalfas S. Lack of lipoprotein- dependent effects on the cytotoxic interactions of Actinobacillus actinomycetemcomitans leukotoxin with human neutrophils. APMIS 2002; 110:857-62; PMID:12645663; http://dx.doi.org/10.1034/j.1600- 0463.2002.1101203.x
79. Johansson A, Claesson R, Belibasakis G, Makoveichuk E, Hanstrom L, Olivecrona G, Sandstrom G, Kalfas S. Protease inhibitors, the responsible components for the serum-dependent enhancement of Actinobacillus actinomycetemcomitans leukotoxicity. Eur J Oral Sci 2001; 109:335-41; PMID:11695755; http://dx.doi. org/10.1034/j.1600-0722.2001.00055.x
80. Johansson A, Claesson R, Hanstrom L, Sandstrom G, Kalfas S. Polymorphonuclear leukocyte degranulation induced by leukotoxin from Actinobacillus actinomycetemcomitans. J Periodontal Res 2000; 35:85-92; PMID:10863962; http://dx.doi.org/10.1034/j.1600- 0765.2000.035002085.x
81. Brage M, Holmlund A, Johansson A. Humoral immune response to Aggregatibacter actinomycetemcomitans leukotoxin. J Periodontal Res 2011; 46:170-5; PMID:21118415; http://dx.doi.org/10.1111/j.1600- 0765.2010.01325.x
82. Paino A, Ahlstrand T, Nuutila J, Navickaite I, Lahti M, Tuominen H, Valimaa H, Lamminmaki U, Pollanen MT, Ihalin R. Identification of a novel bacterial outer membrane interleukin-1Beta-binding protein from Aggregatibacter actinomycetemcomitans. PloS one 2013; 8:e70509; PMID:23936223; http://dx.doi.org/ 10.1371/journal.pone.0070509